Susquehanna International Group Portfolio holdings
Susquehanna International Group (SIG), founded in 1987 by Jeff Yass and a group of friends, is a privately held global quantitative trading and technology firm headquartered in Bala Cynwyd, Pennsylvania. Specializing in trading equities, fixed income, commodities, derivatives, and ETFs, SIG has grown into a major market maker, handling around 600 equity options and 45 index options across exchanges like the CBOE, while employing over 3,000 people worldwide. The firm leverages a data-driven, probabilistic approach—rooted in the founders’ poker-playing days—to provide liquidity and competitive pricing in financial markets, with additional ventures in private equity, venture capital (notably an early investment in ByteDance, TikTok’s parent company), and sports betting analytics. Known for its innovative culture and use of game theory, SIG operates offices across North America, Europe, Asia, and Australia, maintaining a low-profile yet influential presence in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.13B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.04B |
| 3 |
Apple
AAPL
|
+$921M |
| 4 |
Amazon
AMZN
|
+$641M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$475M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.22B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$614M |
| 3 |
Microsoft
MSFT
|
+$602M |
| 4 |
Meta Platforms (Facebook)
META
|
+$576M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$458M |
Sector Composition
| 1 | Technology | 17.62% |
| 2 | Consumer Discretionary | 12.33% |
| 3 | Financials | 8.04% |
| 4 | Healthcare | 6.6% |
| 5 | Communication Services | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Catalyst Pharmaceutical
CPRX
$2.44B
| $1.59M | ﹤0.01% |
135,972
-52,702
| -28% | -$616K |
|
2002
JELD-WEN Holding
JELD
$537M
| $1.58M | ﹤0.01% |
118,489
+48,592
| +70% | +$649K |
|
|
WIRE
2003
DELISTED
Encore Wire Corp
WIRE
| $1.58M | ﹤0.01% |
8,668
-6,246
| -42% | -$1.14M |
|
2004
Celldex Therapeutics
CLDX
$1.62B
| $1.58M | ﹤0.01% |
57,460
+44,576
| +346% | +$1.23M |
|
2005
Mercury Systems
MRCY
$4.34B
| $1.58M | ﹤0.01% |
42,618
-77,336
| -64% | -$2.87M |
|
2006
Virtus Reaves Utilities ETF
UTES
$830M
| $1.58M | ﹤0.01% |
37,932
+5,691
| +18% | +$237K |
|
2007
Brighthouse Financial
BHF
$2.8B
| $1.57M | ﹤0.01% |
32,159
-19,214
| -37% | -$940K |
|
|
AVID
2008
DELISTED
Avid Technology Inc
AVID
| $1.57M | ﹤0.01% |
58,484
-33,552
| -36% | -$902K |
|
2009
Hayward Holdings
HAYW
$3.38B
| $1.57M | ﹤0.01% |
111,450
-70,964
| -39% | -$1M |
|
2010
Pacira BioSciences
PCRX
$1.22B
| $1.57M | ﹤0.01% |
51,129
-7,220
| -12% | -$222K |
|
|
RVNC
2011
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.57M | ﹤0.01% |
136,667
-3,071
| -2% | -$35.2K |
|
2012
Fidelity MSCI Health Care Index ETF
FHLC
$2.46B
| $1.57M | ﹤0.01% |
25,873
+948
| +4% | +$57.4K |
|
2013
ProShares Short S&P500
SH
$1.22B
| $1.57M | ﹤0.01% |
+27,075
| New | +$1.57M |
|
2014
KE Holdings
BEKE
$23.7B
| $1.57M | ﹤0.01% |
100,954
-179,423
| -64% | -$2.78M |
|
2015
Brookfield Renewable
BEP
$7.19B
| $1.56M | ﹤0.01% |
71,934
+46,434
| +182% | +$1.01M |
|
2016
Twist Bioscience
TWST
$1.53B
| $1.56M | ﹤0.01% |
77,121
+37,699
| +96% | +$764K |
|
2017
RPM International
RPM
$16.2B
| $1.56M | ﹤0.01% |
16,473
+8,572
| +108% | +$813K |
|
2018
Global Partners
GLP
$1.77B
| $1.56M | ﹤0.01% |
44,215
+34,045
| +335% | +$1.2M |
|
2019
Ameris Bancorp
ABCB
$5.1B
| $1.56M | ﹤0.01% |
40,661
+7,449
| +22% | +$286K |
|
2020
SPDR S&P Semiconductor ETF
XSD
$1.48B
| $1.56M | ﹤0.01% |
7,958
-5,503
| -41% | -$1.08M |
|
2021
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.17B
| $1.56M | ﹤0.01% |
39,773
+22,875
| +135% | +$896K |
|
|
SILV
2022
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $1.56M | ﹤0.01% |
353,220
-1,682
| -0.5% | -$7.42K |
|
2023
ALPS Sector Dividend Dogs ETF
SDOG
$1.24B
| $1.56M | ﹤0.01% |
33,098
+16,158
| +95% | +$760K |
|
2024
ProShares UltraPro Short Russell2000
SRTY
$79.9M
| $1.55M | ﹤0.01% |
32,766
-6,023
| -16% | -$286K |
|
2025
JPMorgan US Value Factor ETF
JVAL
$549M
| $1.55M | ﹤0.01% |
44,784
+2,487
| +6% | +$86.2K |
|